Modification of Tumor Suppressor Gene Expression in Non-Small Cell Lung Cancer (NSCLC) with a Retroviral Vector Expressing Wildtype (normal) p53. University of Texas M.D. Anderson Cancer Center, Houston, Texas
- 1 May 1996
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (7), 861-874
- https://doi.org/10.1089/hum.1996.7.7-861
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- p53 Mutations in Human CancersScience, 1991
- Activated protooncogenes in human lung tumors from smokers.Proceedings of the National Academy of Sciences, 1991
- Molecular themes in oncogenesisCell, 1991
- p53 mutations in colorectal cancer.Proceedings of the National Academy of Sciences, 1990
- Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.Proceedings of the National Academy of Sciences, 1990
- p53: oncogene or anti-oncogene?Genes & Development, 1990
- Structural and functional properties of ras proteinsThe FASEB Journal, 1989
- Projections of Lung Cancer Mortality in the United States: 1985-20251JNCI Journal of the National Cancer Institute, 1988
- Mutational Activation of the K-rasOncogeneNew England Journal of Medicine, 1987
- Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1Nature, 1983